FDA Clearance Tracker · P150026
HEARTLIGHT ENDOSCOPIC ABLATION SYSTEM
Last checked: Nov 20, 2026Latest source record: Apr 1, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Apr 1, 2016
Approved
Time to decision
246 days
Received Jul 30, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P150026
- Device name
- HEARTLIGHT ENDOSCOPIC ABLATION SYSTEM
- Applicant
- Cardiofocus, Inc.
- Applicant location
- Marlborough, MA
- Received
- Jul 30, 2015
- Decided
- Apr 1, 2016
- Decision
- Approved
- Supplements
- 15 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
The HeartLight® Endoscopic Ablation System is indicated for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OAE. The earliest in FDA's data is P030031-S011, decided Feb 6, 2009.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Cardiofocus, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K152310 · Decided Feb 24, 2016 · 194 days after receipt
Device type: Catheter, Steerable (DRA) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.